Agilent Technologies Inc  

(Public, NYSE:A)   Watch this stock  
Find more results for A
36.22
+0.89 (2.52%)
After Hours: 35.69 -0.53 (-1.46%)
Feb 12, 5:03PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 35.52 - 36.23
52 week 33.12 - 43.59
Open 35.84
Vol / Avg. 3.92M/2.69M
Mkt cap 11.86B
P/E 27.66
Div/yield 0.12/1.27
EPS 1.31
Shares 332.17M
Beta 1.48
Inst. own 87%
Mar 17, 2016
Agilent Technologies Inc Annual Shareholders Meeting (Estimated) - 11:00AM EDT - Add to calendar
Mar 16, 2016
Agilent Technologies Inc Annual Shareholders Meeting - 11:00AM EDT - Add to calendar
Feb 16, 2016
Q1 2016 Agilent Technologies Inc Earnings Call - 4:30PM EST - Add to calendar
Feb 16, 2016
Q1 2016 Agilent Technologies Inc Earnings Release - 4:00PM EST - Add to calendar
Jan 12, 2016
Agilent Technologies Inc at JPMorgan Healthcare Conference
Nov 16, 2015
Q4 2015 Agilent Technologies Inc Earnings Call - Webcast
Nov 16, 2015
Q4 2015 Agilent Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin 13.82% 10.85%
Operating margin 15.07% 12.93%
EBITD margin - 21.55%
Return on average assets 7.79% 4.79%
Return on average equity 13.87% 9.25%
Employees 11,800 -
CDP Score - 77 D

Address

5301 Stevens Creek Blvd
SANTA CLARA, CA 95051-7201
United States - Map
+1-408-3458886 (Phone)
+1-408-3458474 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Company's life sciences and applied markets business segment brings together the Company's analytical laboratory instrumentation and informatics. The Company's diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Company's Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Officers and directors

Michael R. McMullen President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Didier Hirsch Chief Financial Officer, Senior Vice President
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tang Senior Vice President, General Counsel, Secretary
Bio & Compensation  - Reuters
Dominique P. Grau Senior Vice President - Human Resources
Age: 55
Bio & Compensation  - Reuters
Henrik Ancher-Jensen Senior Vice President, President - Order Fulfillment
Age: 49
Bio & Compensation  - Reuters
Mark Doak Senior Vice President; President - Agilent CrossLab Group
Age: 59
Bio & Compensation  - Reuters
Patrick K. Kaltenbach Senior Vice President; President - Life Sciences and Applied Markets Group
Age: 51
Bio & Compensation  - Reuters
Jacob Thaysen Senior Vice President; President - Diagnostics and Genomics Group
Age: 39
Bio & Compensation  - Reuters
Rodney Gonsalves Principal Accounting Officer, Corporate Controller
Bio & Compensation  - Reuters
James G. Cullen Independent Non-Executive Chairman of the Board
Age: 72
Bio & Compensation  - Reuters